Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01718600 · ClinicalTrials.gov registry record
Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions
A clinical trial of Carotid Artery Stenosis, sponsored by Stanford University.
- Completed
- Registry status
- 207
- Enrollment target
- 3
- Study locations
NCT01718600 is a study of Carotid Artery Stenosis that has completed, run by Stanford University. The registered enrollment target is 207 participants, below the 295-participant average among 4 other Carotid Artery Stenosis trials with a reported enrollment target (30% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01718600, a study of Carotid Artery Stenosis, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
- 3
- Study locations
Study Summary
Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinical significance and long-term cognitive effects of microemboli. This proposal may change our current clinical practice by providing a better outcome measure for carotid interventions and improving outcomes of CAS procedures through risk factor stratification. Our central hypothesis is that development of subclinical microemboli is associated with decline in cognitive function following CAS and that the risk of development of microemboli themselves is associated with patient- and procedure-related factors. We hope that this prospective study will help to clarify these important issues in the era of rapidly evolving percutaneous interventions.
Conditions Studied
Interventions
- BEHAVIORAL Neuropsychological testing
Study Locations (3)
California
- Palo Alto Veterans Affairs - Palo Alto
Missouri
- Washington University School of Medicine - St Louis
Wisconsin
- University of Wisconsin, Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2011-06 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01718600
The ClinicalTrials.gov registry entry for NCT01718600 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 295-participant average among 4 other Carotid Artery Stenosis trials with a reported enrollment target (30% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carotid Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Neuropsychological testing is the first listed.
NCT01718600 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Missouri, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01718600 about?
NCT01718600 is a clinical study titled "Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions". Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinic...
What is the current status of trial NCT01718600?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2011-06. Estimated completion is 2018-04.
What conditions does trial NCT01718600 study?
This clinical trial studies the following conditions: Carotid Artery Stenosis.
What interventions are being tested in trial NCT01718600?
The interventions under investigation include: Neuropsychological testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01718600?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01718600 being conducted?
This trial has 3 study locations across California, Missouri, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
ACTIVE NOT RECRUITING · NA
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
ACTIVE NOT RECRUITING · NA
-
The Gore SCAFFOLD Clinical Study
COMPLETED · NA
-
GORE Embolic Protection With Reverse Flow
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.